We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Deaths and Cardiovascular Events in Men Receiving Testosterone

Sandeep Dhindsa, MBBS1; Manav Batra, MBBS2; Paresh Dandona, MBBS2
[+] Author Affiliations
1Division of Endocrinology and Metabolism, Texas Tech University Health Sciences Center, Odessa
2Division of Endocrinology and Metabolism, State University of New York, Buffalo
JAMA. 2014;311(9):964. doi:10.1001/jama.2014.389.
Text Size: A A A
Published online


To the Editor The retrospective study by Dr Vigen and colleagues1 on the association of testosterone therapy with adverse outcomes was limited by the short duration of therapy and the modest increase in testosterone concentrations following treatment.

The duration of treatment on average was approximately 1 year. In clinical terms, this would probably be considered short-term therapy. Also, 40% of patients did not have a testosterone concentration checked after the initiation of testosterone therapy. Of the 60% who had it checked, the testosterone concentration increased from a baseline of 175.5 ng/dL to 332.2 ng/dL for the first repeat testosterone measurement. Because testosterone therapy is generally titrated to raise testosterone level to approximately 500 ng/dL,2 the study population may have been undertreated. Can the authors clarify if the patients had any further increase in testosterone concentration at subsequent measurements?


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




November 6, 2013
Rebecca Vigen, MD, MSCS; Colin I. O’Donnell, MS; Anna E. Barón, PhD; Gary K. Grunwald, PhD; Thomas M. Maddox, MD, MSc; Steven M. Bradley, MD, MPH; Al Barqawi, MD; Glenn Woning, MD; Margaret E. Wierman, MD; Mary E. Plomondon, PhD; John S. Rumsfeld, MD, PhD; P. Michael Ho, MD, PhD
1The University of Texas at Southwestern Medical Center, Dallas
2VA Eastern Colorado Health Care System, Denver3University of Colorado Denver, Aurora
2VA Eastern Colorado Health Care System, Denver3University of Colorado Denver, Aurora4Colorado Cardiovascular Outcomes Research (CCOR) Consortium, Denver
3University of Colorado Denver, Aurora
JAMA. 2013;310(17):1829-1836. doi:10.1001/jama.2013.280386.
March 5, 2014
P. Michael Ho, MD, PhD; Anna E. Barón, PhD; Margaret E. Wierman, MD
1VA Eastern Colorado Health Care System, Denver
JAMA. 2014;311(9):964-965. doi:10.1001/jama.2014.401.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...